Farms.com Home   News

United Ag & Turf Acquires Mustang Equipment

United Ag & Turf, a 28 location John Deere dealership, headquartered in Bryan, Texas, has completed the acquisition of Mustang Equipment, a John Deere Dealership, with locations in Marble Falls, Bulverde and San Antonio, Texas. The acquisition of Mustang Equipment was completed on June 1, 2022.

The newly acquired locations continues to expand United Ag & Turf’s footprint, strengthening the ability to serve customers. “This acquisition continues with our strategy to provide preeminent parts, service, and equipment support and solutions to our customers through efficiency and scale, enabling better pricing and selection for our customers," Brody Pettit, CEO, United Ag & Turf.

As part of the United Ag & Turf network, the newly acquired locations will be now able to offer customers many benefits not available to them in the past; expanded equipment selection and parts inventory, access to a 24 hour on-site mobile service network and a beneficiary of United Ag & Turf’s Support and Solutions Operation Center.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.